Taremi, M., & Mozafari, N. (2025, October). Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris—A Case Report. Clinical Case Reports.
Chicago Style (17th ed.) CitationTaremi, Mahsa, and Nikoo Mozafari. "Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris—A Case Report." Clinical Case Reports Oct. 2025.
MLA (9th ed.) CitationTaremi, Mahsa, and Nikoo Mozafari. "Tofacitinib: A Promising Therapeutic Option for Refractory Pityriasis Rubra Pilaris—A Case Report." Clinical Case Reports, Oct. 2025.
Warning: These citations may not always be 100% accurate.
